GHRH rs1737896: What Your Genotype Means
The rs1737896 variant is a single nucleotide polymorphism located in an intergenic region near the GHRH gene. It has been identified in research as a potential marker associated with multivariate healthy aging and various endocrine-related phenotypes.
What each genotype means
Baseline aging association
This genotype is associated with specific endocrine and healthy aging traits in some research studies. Because the evidence for this variant is limited, these findings should be viewed as statistical associations rather than predictive of individual health outcomes.
Based on a minor allele frequency of approximately 0.30, this genotype is expected to be present in roughly 49% of individuals in European and East Asian populations under Hardy-Weinberg equilibrium.
Baseline aging association
This genotype is associated with specific endocrine and healthy aging traits in some research studies. Because the evidence for this variant is limited, these findings should be viewed as statistical associations rather than predictive of individual health outcomes.
Based on a minor allele frequency of approximately 0.30, this genotype is expected to be present in roughly 42% of individuals in European and East Asian populations under Hardy-Weinberg equilibrium.
Baseline aging association
This genotype is associated with specific endocrine and healthy aging traits in some research studies. Because the evidence for this variant is limited, these findings should be viewed as statistical associations rather than predictive of individual health outcomes.
Based on a minor allele frequency of approximately 0.30, this genotype is expected to be present in roughly 9% of individuals in European and East Asian populations under Hardy-Weinberg equilibrium.
Understanding rs1737896
The variant rs1737896 is a specific genetic change, or single nucleotide polymorphism (SNP), found in the human genome. It is classified as an intergenic variant, meaning it resides in the DNA sequence between genes rather than within the protein-coding regions themselves. Because it is located near the GHRH gene, researchers often study it to determine if it influences the regulation or expression of the nearby growth hormone-releasing hormone. While intergenic variants do not change the structure of a protein directly, they may sit in regulatory elements that control when and how much of a gene product is made. Current scientific catalogs classify this as a trait-associated variant, though the functional mechanisms linking this specific location to biological outcomes remain a subject of ongoing investigation.
The Role of the GHRH Gene
The GHRH gene encodes growth hormone-releasing hormone, a critical signaling molecule produced in the hypothalamus. This hormone travels to the pituitary gland, where it binds to its receptor to stimulate the secretion of growth hormone. Growth hormone is essential for regulating physical growth, metabolism, and various endocrine functions throughout the lifespan. Because GHRH is a master regulator of the growth hormone axis, variations that affect its expression or the sensitivity of its signaling pathway can have broad physiological impacts. While severe mutations in GHRH are known to cause rare growth disorders like dwarfism, common variants like rs1737896 are generally studied for their subtle, cumulative effects on complex traits, such as how the body manages endocrine balance during the aging process.
Research and Evidence Strength
The association between rs1737896 and healthy aging is currently supported by limited evidence. In the context of genetic research, 'limited' indicates that while some studies have observed statistical correlations between this variant and specific endocrine or aging-related traits, these findings have not yet been consistently replicated across large, diverse cohorts to the level of clinical certainty. Genetic associations with complex traits like 'healthy aging' are notoriously difficult to pin down because they involve the interplay of thousands of genetic markers, environmental factors, and lifestyle choices. Consequently, while rs1737896 is a point of interest in the GWAS Catalog and other genomic databases, it should be viewed as a potential contributor to a complex biological puzzle rather than a definitive predictor of any specific health outcome.
Interpreting Your Results
If you have received information about your rs1737896 genotype, it is important to maintain a balanced perspective. This variant is not a diagnostic tool, and it cannot predict your future health or longevity. Because the evidence linking this SNP to specific traits is limited, the presence of a particular allele does not imply a medical condition or a guarantee of healthy aging. You cannot use this information to make medical decisions, change your diet, or alter medication regimens. If you have concerns about your endocrine health, growth, or aging process, the most appropriate step is to consult with a qualified healthcare provider or an endocrinologist. They can evaluate your clinical history and symptoms, which are far more predictive of your health status than any single genetic variant.
How common is this variant?
The minor allele frequency for rs1737896 is approximately 0.30 in both European and East Asian populations, making it a relatively common variant.
Frequently asked questions
Is rs1737896 a cause of disease?
No, rs1737896 is not considered a cause of disease. It is a common genetic variant associated with complex traits in research studies, but it does not have a known pathogenic role in causing specific medical conditions.
Can I use this SNP to predict my lifespan?
No. While the variant has been studied in the context of healthy aging, it is not a predictor of lifespan. Aging is a highly complex process influenced by many genes and environmental factors.
Should I see a doctor because of this variant?
There is no medical reason to see a doctor based solely on this variant. If you have specific health concerns, you should discuss them with your physician regardless of your genetic results.
Why is the evidence for this variant called 'limited'?
Evidence is labeled 'limited' when research findings are preliminary or have not been consistently replicated across large, diverse populations. It means we do not yet have enough data to draw firm conclusions about the variant's impact.
Sources & further reading
Educational information only, last refreshed 9/29/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1737896?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29